Analysis

  • Comment: COVID-19 - beyond 1-in-200

    23 April 2020

    Gareth Mee looks at how the insurance industry is responding to the far-reaching financial impacts of Coronavirus

  • Dialling up the asset management products in China

    21 April 2020

    New regulatory guidelines in China for insurers' asset management products could electrify the once contentious $400bn market. David Walker reports

  • Comment: Pastures new - ALM in today's reporting environment

    20 April 2020

    Stuart Jarvis looks at how reporting rules have developed and why they are tightening, and how insurers can approach investment decisions in the new ALM landscape.

  • IFRS 9 implementation - the sooner one starts the better

    15 April 2020

    Based on their experience with a joint insurance clients, JP Morgan Asset Management and Clearwater Analytics discuss the ins and outs of implementing the accounting standard, and why insurers should start early. Interview by Vincent Huck

  • CIOs start assessing 'what next', despite continued volatility

    13 April 2020

    Investment markets look for brighter days even while the gloomiest persist. Some insurers' chief investment officers are doing the same, as David Walker reports

  • Suspension of dividend payments, more firepower for the investment teams?

    09 April 2020

    As some insurers follow suit on regulators' urge not to pay dividends and others refuse to comply, Vincent Huck looks at whether dividend retention could result in more ammunition for the investment teams to invest in markets

  • Asset risk: Open hunting season or fool's gold?

    07 April 2020

    Sarfraz Thind takes a deep dive into how Covid-19 has distorted the market. In part one of this two part series he looks at commercial mortgage-backed securitisations (CMBS), collateralised loan obligation (CLO) and municipal bonds.

  • IAR SURVEY: Insurers unprepared for COVID-19's market turbulence

    06 April 2020

    Insurance Asset Risk surveyed the industry to find out how it is rethinking asset allocation in the wake of COVID-19's impact on the economy and financial markets. Vincent Huck presents the results

  • No yield, too few bunds - what investment trials mean for 2020 Review

    03 April 2020

    Frank Schiller, board member of the DAV, tells David Walker in a far ranging interview his thoughts on the 2020 Solvency II review and where he believes EIOPA needs to step up its work.

  • SII reporting delays: thanks but no thanks

    01 April 2020

    As European regulators offer some leeway on Solvency II regulatory reporting deadlines, insurers seem inclined to follow the original schedule. Begging the question of how to account for the COVID-19 impact. David Walker reports

Most Read
  1. M&G JV with Asian pension fund to invest £1bn in UK housing
  2. Insurance sector the "natural home" of productive assets, L&G says
  3. Barings acquires Sydney office building for AU $360m
  4. BoE zeroes in on private market risks to insurers and UK financial system
  5. Meiji Yasuda expands backing of regional revitalisation startup
  6. Insurance Development Forum reaches first close on Infrastructure Resilience Development Fund
  7. Chart of the Week - The rise and rise of (small) insurers investing in private assets
  8. Aviva Investors finances £175m loan for acquisition of central London property
  9. Private credit: the feel-good factor?
  10. Private credit: are headline news and underlying performance one and the same?